17-8161461-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014232.3(VAMP2):c.334+12G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.228 in 1,613,590 control chromosomes in the GnomAD database, including 44,171 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.20 ( 3300 hom., cov: 32)
Exomes 𝑓: 0.23 ( 40871 hom. )
Consequence
VAMP2
NM_014232.3 intron
NM_014232.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.588
Genes affected
VAMP2 (HGNC:12643): (vesicle associated membrane protein 2) The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. This gene is thought to participate in neurotransmitter release at a step between docking and fusion. The protein forms a stable complex with syntaxin, synaptosomal-associated protein, 25 kD, and synaptotagmin. It also forms a distinct complex with synaptophysin. It is a likely candidate gene for familial infantile myasthenia (FIMG) because of its map location and because it encodes a synaptic vesicle protein of the type that has been implicated in the pathogenesis of FIMG. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 17-8161461-C-G is Benign according to our data. Variant chr17-8161461-C-G is described in ClinVar as [Benign]. Clinvar id is 1321621.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.248 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VAMP2 | NM_014232.3 | c.334+12G>C | intron_variant | ENST00000316509.11 | NP_055047.2 | |||
VAMP2 | NM_001330125.1 | c.340+12G>C | intron_variant | NP_001317054.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VAMP2 | ENST00000316509.11 | c.334+12G>C | intron_variant | 1 | NM_014232.3 | ENSP00000314214.6 | ||||
ENSG00000263620 | ENST00000498285.1 | c.334+12G>C | intron_variant | 4 | ENSP00000464383.1 |
Frequencies
GnomAD3 genomes AF: 0.201 AC: 30535AN: 152030Hom.: 3296 Cov.: 32
GnomAD3 genomes
AF:
AC:
30535
AN:
152030
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.192 AC: 48228AN: 250746Hom.: 5254 AF XY: 0.198 AC XY: 26831AN XY: 135488
GnomAD3 exomes
AF:
AC:
48228
AN:
250746
Hom.:
AF XY:
AC XY:
26831
AN XY:
135488
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.231 AC: 337337AN: 1461442Hom.: 40871 Cov.: 33 AF XY: 0.230 AC XY: 167155AN XY: 727000
GnomAD4 exome
AF:
AC:
337337
AN:
1461442
Hom.:
Cov.:
33
AF XY:
AC XY:
167155
AN XY:
727000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.201 AC: 30559AN: 152148Hom.: 3300 Cov.: 32 AF XY: 0.196 AC XY: 14582AN XY: 74374
GnomAD4 genome
AF:
AC:
30559
AN:
152148
Hom.:
Cov.:
32
AF XY:
AC XY:
14582
AN XY:
74374
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
382
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2021 | - - |
Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at